JPMorgan Chase & Co. purchased a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 49,322 shares of the company's stock, valued at approximately $1,382,000. JPMorgan Chase & Co. owned approximately 0.15% of Bowhead Specialty at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in BOW. Point72 Asset Management L.P. bought a new stake in Bowhead Specialty during the second quarter worth about $117,000. MetLife Investment Management LLC acquired a new stake in shares of Bowhead Specialty in the 3rd quarter valued at approximately $123,000. New Vernon Investment Management LLC bought a new position in shares of Bowhead Specialty in the third quarter valued at $127,000. Quantbot Technologies LP acquired a new position in Bowhead Specialty during the third quarter worth $157,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in Bowhead Specialty during the second quarter worth $192,000.
Bowhead Specialty Price Performance
Shares of NYSE BOW traded up $0.46 during trading hours on Friday, reaching $31.85. 93,038 shares of the stock were exchanged, compared to its average volume of 115,709. The stock's fifty day simple moving average is $34.51 and its 200 day simple moving average is $30.94. Bowhead Specialty Holdings Inc. has a 52 week low of $22.14 and a 52 week high of $37.81.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.38 earnings per share for the quarter, hitting the consensus estimate of $0.38. The firm had revenue of $116.76 million for the quarter, compared to the consensus estimate of $113.00 million. Equities research analysts predict that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current year.
Wall Street Analysts Forecast Growth
BOW has been the subject of a number of analyst reports. Royal Bank of Canada lifted their price objective on shares of Bowhead Specialty from $32.00 to $35.00 and gave the company an "outperform" rating in a research report on Wednesday, November 6th. JPMorgan Chase & Co. boosted their price target on Bowhead Specialty from $26.00 to $30.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. JMP Securities raised their price objective on Bowhead Specialty from $32.00 to $33.00 and gave the company a "market outperform" rating in a research report on Wednesday, November 6th. Finally, Keefe, Bruyette & Woods boosted their target price on Bowhead Specialty from $36.00 to $44.00 and gave the stock a "market perform" rating in a report on Friday, January 10th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Bowhead Specialty has a consensus rating of "Hold" and an average price target of $33.60.
Check Out Our Latest Analysis on BOW
Bowhead Specialty Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.